Ambrx
is a California-based biopharmaceutical company that researches and develops antibody drug conjugates for the treatment of cancer... Read moreAmbrx
is a California-based biopharmaceutical company that researches and develops antibody drug conjugates for the treatment of cancer... Read more
News
Mar 08, 2024
Pharamceutical Technology
Ambrx: Johnson & Johnson acquires Ambrx Biopharma for $2bn
Mar 07, 2024
Citybizlist
Ambrx: Johnson & Johnson Completes Acquisition of Ambrx
Feb 13, 2024
Bloomberg Law
Ambrx: J&J's $2 Billion Ambrx Buyout Draws Shareholder Legal Challenges
Feb 08, 2024
Pharamceutical Technology
Ambrx: Anvatabart opadotin by Ambrx Biopharma for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Jan 27, 2024
MarketScreener
Ambrx: AMBRX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ambrx Biopharma, Inc. - AMAM
Jan 23, 2024
Law 360
Ambrx: Freshfields Bolsters M&A Practice With Cravath Partner
Jan 09, 2024
Zacks
Ambrx: Ambrx (AMAM) Skyrockets 102% on $2B Buyout Offer From J&J
Jan 09, 2024
The San Diego Union Tribune
Ambrx: Johnson & Johnson buys San Diego's Ambrx Biopharma for $2B
Jan 08, 2024
iNVEZZ
Ambrx: Ambrx Biopharma stock doubles on JNJ deal
Jan 08, 2024
MarketScreener
Ambrx: Johnson & Johnson to Acquire Cancer-Treatment Developer Amrbx for $2 Billion
Ambrx Competitors
1
2
3
4
5
6
7
8
9